Episode 6: The Rise of the Chiral Switch: Strategy or Science?
“When a drug transforms from a blend to a single hand, is it innovation -or a clever commercial sleight of hand?“ Introduction The regulatory awakening around chiral drugs enabled not just better science but also a new strategic tool for the pharmaceutical industry: the chiral switch. This phenomenon -developing a single-enantiomer version of an already marketed racemate -became both a scientific opportunity and a commercial strategy. While some switches were genuine innovations that improved patient …
Episode 6: The Rise of the Chiral Switch: Strategy or Science? Read More »